Twin Tree Management, LP Novo Cure LTD Call Options Transaction History

Twin Tree Management, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $2.95 Million - $4.53 Million	-23,800 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $897,280 - $1.39 Million	-8,000 Reduced 25.16%	23,800 $4.12 Million
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $1.85 Million - $3.54 Million	31,800 New	31,800 $3.54 Million
Q2 2020 Aug 12, 2020	SELL	$57.2 - $74.41 $2.03 Million - $2.64 Million	-35,500 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$57.05 - $95.75 $986,965 - $1.66 Million	17,300 Added 95.05%	35,500 $2.39 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $1.24 Million - $1.71 Million	18,200 New	18,200 $1.53 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.